G. Falardeau

Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease.

F. Maltais, P. Leblanc, J. Jobin, 1997, American journal of respiratory and critical care medicine.

Pyrido [1,2a] Indole Derivatives Identified as Novel Nonnucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1

J. Bédard, P. Chambers, J. Duchaine, 1999, Antiviral chemistry & chemotherapy.

Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors.

L. Chan, J. Bédard, H. Jin, 1999, Journal of medicinal chemistry.

Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors.

L. Chan, C. Yannopoulos, J. Bédard, 2005, Bioorganic & medicinal chemistry letters.

Substituted 1,6-naphthyridines as human cytomegalovirus inhibitors: conformational requirements.

L. Chan, H. Jin, T. Stefanac, 2000, Bioorganic & Medicinal Chemistry Letters.

Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic cores.

L. Chan, S. Das, Oswy Z. Pereira, 2015, Bioorganic & medicinal chemistry letters.

Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines.

L. Chan, J. Bédard, H. Jin, 2001, Bioorganic & medicinal chemistry letters.

Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potency.

L. Chan, S. Das, Oswy Z. Pereira, 2015, Bioorganic & medicinal chemistry letters.